Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2012


6th Neurodegenerative Conditions Research and Development

13 Sep 2012 - 14 Sep 2012 - San Fracisco, CA, Hilton San Francisco Financial District



Bookmark and Share


Following on the heels of success with our previous five Neurodegenerative Diseases Drug Discovery conferences, we are proud to bring another comprehensive and timely summit 6th Neurodegenerative Conditions Research and Development on Sept 13-14, 2012 in San Francisco, CA.

The drug discovery effort for neurodegenerative diseases has been one of the major challenges and focuses of the pharmaceutical industry, which has been evidenced by fast and dynamic research and development in this field. Though several clinical trials for Alzheimer's failed in the last couple of years, there has been great progress in the development of novel therapeutic approaches and targets to treat Alzheimer’s as well as Parkinson’s, Huntington’s, multiple sclerosis, stroke and various other neurodegenerative diseases. Some of these novel approaches include biomarkers, stem cell therapy, protein misfolding and aggregation, immunotherapy, vaccines for Alzheimer's, BACE inhibitors, and much more. There have also been significant developments in our understanding of the genetics, the molecular mechanisms and signaling pathways contributing to neuronal dysfunction, neurotoxicity and pathology.



Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!